Identification of HLA-DQα and -DRβ residues associated with susceptibility and protection to epithelial ovarian cancer

Human Immunology

Volumn 66, Issue 5, 2005, Pages 554-562

  Monos, Dimitri S ^a,b   Pappas, John ^c   Magira, Eleni E ^a   Gaughan, John ^c   Aplenc, Richard ^a   Sakkas, Lazaros ^c   Freedman, Ralph ^d   Reveille, John D ^e   Platsoucas, Chris D ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Disease susceptibility; HLA DQ ; HLA DR ; Ovarian cancer; Protection

Indexed keywords

EPITOPE; HLA DQ ALPHA ANTIGEN; HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR BETA ANTIGEN; HLA DR1 ANTIGEN; UNCLASSIFIED DRUG; HLA DQALPHA ANTIGEN; HLA-DQALPHA ANTIGEN;

ARTICLE; CANCER PREVENTION; CANCER SUSCEPTIBILITY; COMPARATIVE STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; OVARY CARCINOMA; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; AMINO ACID SEQUENCE; DISEASE PREDISPOSITION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; MOLECULAR GENETICS; NEOPLASM; OVARY TUMOR;

AMINO ACID SEQUENCE; DISEASE SUSCEPTIBILITY; EPITOPES, T-LYMPHOCYTE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 20444416741     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2005.01.019     Document Type: Article

References (65)

1. A.P. Makar, M. Baekelandt, G. Trope, G.B. Kristensen The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer Gynecol Oncol 56 1995 175
2. S. Marsoni, V. Torri, M.G. Valsecchi, C. Belloni, U. Bianchi, G. Bolis, C. Boanzzi, N. Colombo, A. Epis, G. Favalli Prognostic factors in advanced epithelial ovarian cancer. Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG) Br J Cancer 62 1990 444
3. R.T. Greenlee, T. Murray, S. Bolden, P.A. Wingo Cancer statistics, 2000 CA Cancer J Clin 50 2000 7
4. C.D. Platsoucas, J.E. Fincke, J. Pappas, W.J. Jung, M. Heckel, R. Schwarting, E. Magira, D. Monos, R.S. Freedman Immune responses to human tumors development of tumor vaccines Anticancer Res 23 2003 1969
5. R.S. Freedman, B. Tomasovic, S. Templin, E.N. Atkinson, A. Kudelka, C.L. Edwards, C.D. Platsoucas Large scale expansion in IL-2 of TIL from patients with ovarian carcinoma for adoptive immunotherapy J Immunol Methods 167 1994 145
6. R.S. Freedman, C. Edwards, J. Kavanagh, A. Kudelka, R.L. Katz, C.H. Carrasco, E.N. Atkinson, B. Tomasovic, C.D. Platsoucas Intraperitoneal adoptive immunotherapy of ovarian carcinoma with TIL and low dose rIL2 a pilot trial J Immunother 16 1994 198
7. L. Zhang, J.R. Conejo-Garcia, D. Katsaros, P.A. Gimotty, M. Massobrio, G. Regnani, A. Makrigiannakis, H. Gray, K. Schlienger, M.N. Liebman, S.C. Rubin, G. Coukos Intratumoral T cells, recurrence and survival in epithelial ovarian cancer N Engl J Med 348 2003 203
8. C.G. Ioannides, C.D. Platsoucas, S. Rashed, C. Edwards, R.S. Freedman Tumor cytolysis by lymphocytes infiltrating malignant ascites Cancer Res 51 1991 4257
9. C.G. Ioannides, R.S. Freedman, C.D. Platsoucas, S. Rashed, Y.P. Kim Cytotoxic T cell clones isolated from ovarian TIL recognize multiple antigenic epitopes on autologous tumor cells J Immunol 146 1991 1700
10. R.S. Freedman, C.D. Platsoucas Immunotherapy for peritoneal ovarian carcinoma metastasis using in vitro expanded TIL Cancer Treatment Res 82 1996 115
11. R.S. Freedman, A.P. Kudelka, C.F. Verschraegen, C.D. Platsoucas Progress toward tumor-specific immunity in carcinomas of the ovary and breast J.J. Kavanagh S.E. Singletary N. Einhorn A.D. DePetrillo Cancer in Women 1998 Blackwell Science Malden, UK
12. S. Kooi, R.S. Freedman, J. Rodriguez-Villanueva, C.D. Platsoucas Cytokine production by T-cell lines derived from TIL from patients with ovarian carcinoma tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells Lymph Cytokine Res 12 1993 429
13. G.E. Peoples, P.S. Goedegebuure, J.V. Andrews, D.D. Schoof, T.J. Eberlein HLA-A2 presents shared tumor-associated antigens derived from endogenous proteins in ovarian cancer J Immunol 151 1993 5481
14. G.E. Peoples, P.S. Goedegebuure, R. Smith, D.C. Linehan, I. Yoshino, T.J. Eberlein Breast and ovarian cancer-specific CTL recognize the same HER2/neu-derived peptide Proc Natl Acad Sci U S A 92 1995 432
15. G.E. Peoples, I. Yoshino, C.C. Douville, J.V. Andrews, P.S. Goedegebuure, T.J. Eberlein TCR Vβ3+ and Vβ6+ CTL recognize tumor-associated antigens related to HER2/neu expression in HLA-A2+ ovarian cancers J Immunol 152 1994 4993
16. I. Yoshino, G.E. Peoples, P.S. Goedegebuure, R. Maziarz, T.J. Eberlein Association of HER2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancer J Immunol 152 1994 2393
17. P.F. Chen, C.D. Platsoucas Development of the non-palindromic adaptor polymerase chain reaction for the amplification of α-and β-chain human T-cell receptor cDNAs Scand J Immunol 35 1992 539
18. C.A. Slachta, V. Jeevanandam, B. Goldman, W.L. Lin, C.D. Platsoucas Coronary arteries from human cardiac allografts with chronic rejection contain oligoclonal populations of T cells. Persistence of identical clonally expanded beta-chain T-cell receptor transcripts from the early posttransplantation period (endomyocardial biopsies) to chronic rejection (coronary arteries) J Immunol 165 2000 3469
19. E.L. Oleszak, W.L. Lin, A. Legido, J. Melvin, H. Hardison, B.E. Hoffman, C.D. Katsetos, C.D. Platsoucas Presence of oligoclonal T cells in cerebrospinal fluid of a child with multiphasic disseminated encephalomyelitis following hepatitis A virus infection Clin Diagn Lab Immunol 8 2001 984
20. L.I. Sakkas, B. Xu, C. Artlett, S. Jimenez, C.D. Platsoucas Oligoclonal T-cell expansion in the skin of patients with systemic sclerosis J Immunol 168 2002 3649
21. J. Pappas, W.L. Lin, C.W. Helm, R.S. Freedman, C.D. Platsoucas Clonally expanded T cell receptor (TCR) transcripts in ovarian tumor infiltrating lymphocytes (TIL) Scand J Immunol 54 Suppl 1 2001 70 K1.Wed.3.13a/13a7
22. T. Boon, P. Van der Bruggen Human tumor antigens recognized by T lymphocytes J Exp Med 183 1996 725
23. S.A. Rosenberg, Y. Kawakami, P.F. Robbins, R. Wang Identification of the gene encoding cancer antigens implications for cancer immunotherapy Adv Cancer Res 70 1996 145
24. A.M. Gillespie, S. Rodgers, A.P. Wilson, J. Tidy, R.C. Rees, R.E. Coleman, A.K. Murray MAGE, BAGE and GAGE tumour antigen expression in benign and malignant ovarian tissue Br J Cancer 78 1998 816
25. V. Russo, P. Dalerba, A. Ricci, C. Bonazzi, B.E. Leone, C. Mangioni, P. Allavena, C. Bordignn, C. Traversari MAGE, BAGE and GAGE genes expression in fresh epithelial ovarian carcinomas Int J Cancer 67 1996 457
26. M.P. Vierboom, H.W. Nijman, R. Offringa, E.I. van der Voort, T. van Hall, L. van den Broek, G.J. Fleuren, P. Kenemans, W.M. Kast, C.F. Melief Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes J Exp Med 186 1997 695
27. M.L. Disis, J.W. Smith, A.E. Murphy, W. Chen, M.A. Cheever In vitro generation of human cytolytic T-cells specific for peptides derived from the HER-2/neu protooncogene protein Cancer Res 54 1994 1071
28. S. Zotter, A. Lossnitzer, P.C. Hageman, W.J. Mooi, J. Hilgers Tissue and tumor distribution of human polymorphic epithelial mucin Cancer Rev 55 1988 11
29. K.L. Knuston, K. Schiffman, M.L. Disis Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patient J Clin Invest 107 2001 477
30. K.L. Knuston, M.L. Disis Clonal diversity of the T-cell population responding to a dominant HLA-A2 epitope of HER-2/neu after active immunization in an ovarian cancer patient Hum Immunol 63 2002 547
31. M.L. Disis, K.H. Grabstein, P.R. Sleath, M.A. Cheever Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine Clin Cancer Res 5 1999 1289
32. S. Kooi, H.-Z. Zhang, R. Patenia, C. Edwards, C.D. Platsoucas, R.S. Freedman HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of rIL-2 Cell Immunol 174 1996 116
33. J.D. Reveille, E. Durban, M.J. MacLeod-St Clair, R. Goldstein, R. Moreda, R.D. Altman, F.C. Arnett Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis) J Clin Invest 90 1992 973
34. F. Obata, K. Ito, T. Kaneko, Y.H. Yang, K. Onda, I. Ito, N. Yabe, K. Watanabe, N. Kashiwagi HLA-DR gene frequencies in the Japanese population obtained by oligonucleotide genotyping Tissue Antigens 38 1991 124
35. T.L. Bugawan, A.B. Begovich, H.A. Erlich Rapid HLA-DPB typing using enzymatically amplified DNA and nonradioactive sequence-specific oligonucleotide probes Immunogenetics 32 1990 231
36. M. Ballas, G. Oechsle, T.H. Eiermann, C. Muller, A. Wopl, S.F. Goldmann A DRB oligonucleotide typing system defining 50 of 56 DRB alleles K. Tsuji M. Aizawa T. Sasazuki Proceedings of the 11th International Histocompatibility Workshop and Conference 1992 Oxford University Press New York
37. A. Svejgaard, L.P. Ryder HLA and disease associations detecting the strongest association Tissue Antigens 43 1994 18
38. L. Zerva, B. Cizman, N.K. Mehra, S.K. Alahari, R. Murali, C.M. Zmijewski, M. Kamoun, D.S. Monos Arginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy J Exp Med 183 1996 829
39. E.E. Magira, M. Papaioakim, I. Nachamkin, A.K. Ashbury, C.Y. Li, T.W. Ho, J.W. Griffin, G.M. McKhann, D.S. Monos Differential distribution of HLA-DQβ/DRβ epitopes in the two forms of Guillain-Barré syndrome (GBS), acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy (AIDP) Identification of DQβ epitopes associated with susceptibility and protection to AIDP J Immunol 170 2003 3074
40. R.W. Karr, P. Panina-Bordignon, W.Y. Yu, A. Lanzavecchia Antigen-specific T cells with monogamous or promiscuous restriction patterns are sensitive to different HLA-DR beta chain substitutions J Immunol 146 1991 4242
41. R.R. Olson, M.T. DeMagistris, A. DiTommaso, R.W. Karr Mutations in the third, but not the first or second, hypervariable regions of DRB1* (*)0101 eliminate DR1-restricted recognition of a pertussis toxin peptide J Immunol 148 1992 2703
42. X.T. Fu, C.P. Bono, S.L. Woulfe Pocket 4 of the HLA-DR (* (*)0401) molecule is a major determinant of T cell recognition of peptide J Exp Med 181 1995 915
43. P.K. Gregersen, J. Silver, R.J. Winchester The shared epitope hypothesis an approach to understanding the molecular genetics of suspectibility to rheumatoid arthritis Arthritis Rheum 30 1987 1205
44. E. Zanelli, F.C. Breedveld, R.R. de Vries HLA class II association with rheumatoid arthritis facts and interpretations Hum Immuol 61 2000 1254
45. M.D. Rossman, J. Stubbs, W.W. Lee, E. Argyris, E. Magira, D. Monos HLA amino acid epitopes susceptibility and progression markers for beryllium hypersensitivity Am J Respir Crit Care Med 165 2002 788
46. I. Khalil, L. d'Auriol, M. Gobet A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus J Clin Invest 85 1990 1315
47. D.H. Fremont, W.A. Hendrickson, P. Marrack, J. Kappler Structures of an MHC class II molecule with covalently bound single peptides Science 272 1996 1001
48. E. Sundberg, T.S. Jardetzky Structural basis for HLA-DQ binding by the streptococcal superantigen SSA Nat Struct Biol 6 1999 123
49. I. Potolicchio, G. Mosconi, A. Forni, B. Nemery, P. Seghizzi, R. Sorrentino Susceptibility to hard metal lung disease is strongly associated with the presence of glutamate 69 in HLA-DPβ chain Eur J Immunol 27 1997 2741
50. H.P. Rihs, K. Conrad, J. Mehihorn Molecular analysis of HLA-DPB1 alleles in idiopathic systemic sclerosis patients and uranium miners with systemic sclerosis Int Arch Allergy Immunol 109 1996 216
51. G.M. Taylor, D.A. Gokhale, D. Crowther, P.J. Woll, M. Harris, D. Ryder, M. Ayes, J.A. Radford Further investigation of the role of HLA-DP B1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes Br J Cancer 80 1999 1405
52. V. Lotteau, L. Teyton, D. Burroughs, D. Charron A novel HLA class II molecule (DR alpha-DQ beta) created by mismatched isotype pairing Nature 329 1987 339
53. E. Zanelli, C.J. Krco, J.M. Baischi, S. Cheng, C.S. David Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis Proc Natl Acad Sci U S A 22 1996 1814
54. P. Das, S. Bradley, A. Geluk, M.M. Griffiths, H.S. Luthra, C.S. David HLA-DRB1* (*)0402 derived peptide (HV3 65-79) prevents collagen-induced arthritis in HLA-DQ8 transgenic mice Hum Immunol 60 1999 575
55. Y. Park, G.S. Eisenbarth Genetic susceptibility factors of type 1 diabetes in Asians Diabetes Metab Res Rev 17 2001 2
56. J.E. Lee, J.D. Reveille, M.I. Ross, C.D. Platsoucas HLA-DQB1* (*)0301 association with increased cutaneous melanoma risk Int J Cancer 59 1994 510
57. J.E. Lee, J.C. Reveille, C.D. Platsoucas Association of HLA-DOB1* (*)0301 with malignant melanoma J Immunother 19 1996 381
58. J.E. Lee, M. Lu, P.F. Mansfield, C.D. Platsoucas, J.D. Reveille, M.I. Ross Malignant melanoma relationship of the human leukocyte antigen class II gene DQB1* (*)0301 to disease recurrence in American Joint Committee on Cancer Stage I or II Cancer 78 1996 758
59. A.C. Bateman, S.J. Turner, J.M. Theaker, W.M. Howell HLA-DQB1* (*)0303 and * (*)0301 alleles influence susceptibility to and prognosis in cutaneous malignant melanoma in the British Caucasian population Tissue Antigens 52 1998 67
60. H. Uno, K. Kawano, H. Matsuoka, K. Tsuda HLA and adult T cell leukaemia HLA-linked genes controlling susceptibility to human T cell leukaemia virus type I Clin Exp Immunol 71 1988 211
61. J. Cuzick, G. Terry, L. Ho, J. Monaghan, A. Lopes, P. Clarkson, I. Duncan Association between high-risk HPV types, HLA DRB1* (*) and DQB1* (*) alleles and cervical cancer in British women Br J Cancer 82 2000 1348
62. R. Wank, C. Thomssen High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3 Nature 352 1991 723
63. A. Helland, A.L. Borresen, J. Kaern, K.S. Ronningen, E. Thorsby HLA antigens and cervical carcinoma Nature 356 1992 23
64. J.C. Delgado, D. Turbay, E.J. Yunis A common major histocompatibility complex class II allele HLA-DQB1* (*)0301 is present in clinical variants of pemphigoid Proc Natl Acad Sci U S A 93 1996 8569
65. I. Khalil, V. Lepage, C. Douay HLA DQB1* (*)0301 allele is involved in the susceptibility to erythema multiforme J Invest Dermatol 97 1991 697